Animal Models to Study Emerging Technologies Against SARS-CoV-2

被引:0
|
作者
Jhinuk Basu Mullick
Chelsey S. Simmons
Janak Gaire
机构
[1] University of Florida,Department of Mechanical & Aerospace Engineering, Herbert Wertheim College of Engineering
[2] University of Florida,Division of Cardiovascular Medicine, J. Crayton Pruitt Family Department of Biomedical Engineering
来源
关键词
COVID-19; ACE2 receptor; Vaccine studies; Pathogenesis; Diagnostics; Transgenic models; Non-human primates; Domestic pets; Farm animals;
D O I
暂无
中图分类号
学科分类号
摘要
New technologies are being developed toward the novel coronavirus SARS-CoV-2 to understand its pathogenesis and transmission, to develop therapeutics and vaccines, and to formulate preventive strategies. Animal models are indispensable to understand these processes and develop and test emerging technologies; however, the mechanism of infection for SARS-CoV-2 requires certain similarities to humans that do not exist in common laboratory rodents. Here, we review important elements of viral infection, transmission, and clinical presentation reflected by various animal models readily available or being developed and studied for SARS-CoV-2 to help bioengineers evaluate appropriate preclinical models for their emerging technologies. Importantly, applications of traditional mice and rat models are limited for studying SARS-CoV-2 and development of COVID-19. Non-human primates, Syrian hamsters, ferrets, cats, and engineered chimeras mimic the human infection more closely and hold strong potential as animal models of SARS-CoV-2 infection and progression of resulting human disease.
引用
收藏
页码:293 / 303
页数:10
相关论文
共 50 条
  • [41] Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models
    Mazunina, Elena P.
    Gushchin, Vladimir A.
    Bykonia, Evgeniia N.
    Kleymenov, Denis A.
    Siniavin, Andrei E.
    Kozlova, Sofia R.
    Mukasheva, Evgenya A.
    Shidlovskaya, Elena V.
    Kuznetsova, Nadezhda A.
    Usachev, Evgeny V.
    Zlobin, Vladimir I.
    Burtseva, Elena I.
    Ivanov, Roman A.
    Logunov, Denis Y.
    Gintsburg, Alexander L.
    VACCINES, 2024, 12 (11)
  • [42] Mouse Models for the Study of SARS-CoV-2 Infection
    Knight, Audrey C.
    Montgomery, Stephanie A.
    Fletcher, Craig A.
    Baxter, Victoria K.
    COMPARATIVE MEDICINE, 2021, 71 (05) : 383 - 397
  • [43] A VACCINE AGAINST SARS-COV-2
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
  • [44] Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
    Feng, Xuemei
    Wang, Hu
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (07) : 925 - 942
  • [45] Neutralization against emerging Omicron subvariants after SARS-CoV-2 reinfection
    Tian, Shen
    Liu, Ti
    Zhao, Xin-Jing
    Liu, Xiao-Lin
    Li, Xin-Lou
    Du, Kai-Ge
    Fang, Li-Qun
    Kou, Zeng-Qiang
    Wei, Yue-Hong
    Wang, Guo-Lin
    JOURNAL OF INFECTION, 2023, 87 (06) : 598 - 601
  • [46] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [47] Emerging neurotropic features of SARS-CoV-2
    Zhan, Wen-Rong
    Huang, Jing
    Zeng, Peng-Ming
    Tian, Wei-Ya
    Luo, Zhen-Ge
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (10) : 705 - 711
  • [48] Organoid Technologies for SARS-CoV-2 Research
    Khiry Sutton
    Timothy Leach
    Vikram Surendran
    Phillip Clapp
    Sean Murphy
    Current Stem Cell Reports, 2022, 8 : 151 - 163
  • [49] Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
    Zhang, Jianzhong
    Xia, Yutian
    Liu, Xuan
    Liu, Gang
    BIOENGINEERING-BASEL, 2023, 10 (02):
  • [50] A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
    Ramin Lotfi
    Rasoul Nasiri Kalmarzi
    Seyed Askar Roghani
    Immunologic Research, 2021, 69 : 213 - 224